rethinkPeptides Search
Menu
Study breakdown

Ipamorelin Still Releases Growth Hormone and Promotes Growth Even During Steroid Treatment

Animal StudyPreliminary evidence
The takeaway

Ipamorelin maintained its GH-releasing ability and growth-promoting effects in rats receiving methylprednisolone, overcoming the typical GH suppression caused by glucocorticoid treatment.

Steroid-resistant GH release

Ipamorelin maintained its GH-stimulating effect despite methylprednisolone treatment that typically suppresses GH

What the researchers found

Ipamorelin maintained GH-releasing activity during 8 days of methylprednisolone treatment in rats and partially preserved longitudinal bone growth over 15 days despite glucocorticoid-induced growth suppression.

Why it matters

Children on chronic steroids (for asthma, autoimmune diseases, transplants) often fail to grow properly. A GH secretagogue that works despite steroids could preserve their growth and development.

How the study worked

Two animal experiments in rats: (1) GH release after ipamorelin with/without 8-day MP treatment, (2) 15-day bone growth study with ipamorelin during MP administration. Plasma GH and tibial bone growth measured.

What this study cannot tell us

Rat study. Bone growth was only partially preserved, not fully restored. The mechanism by which ipamorelin bypasses glucocorticoid suppression was not determined. Human pediatric data needed.

How to read the evidence

Preliminary animal evidence with clinically relevant experimental design (GH secretagogue during steroid treatment), but limited to rats.

When this study was published

Published in 1999. The concept of using GH secretagogues to counteract steroid-induced growth suppression remains clinically relevant.

The bigger picture

Steroid-induced growth suppression is a major pediatric problem. If ipamorelin can bypass the GH-suppressive effects of steroids, it could be combined with steroid therapy to protect growth in the millions of children who need chronic glucocorticoids.

Questions still open

  • Could ipamorelin prevent growth stunting in children on chronic steroids?
  • Does ipamorelin bypass somatostatin-mediated GH suppression by steroids?
  • What is the optimal ipamorelin dose to counteract steroid growth suppression?

Common questions

Why do steroids stunt growth?
Glucocorticoid steroids suppress growth hormone release and directly interfere with bone growth. Children who need chronic steroids for conditions like asthma or autoimmune diseases often end up shorter than expected.
Could ipamorelin help these children?
This animal study suggests yes — ipamorelin can release GH even when steroids are suppressing the normal GH system. If confirmed in children, it could be given alongside steroid therapy to protect growth.

Read the original research

Methylprednisolone does not inhibit the release of growth hormone after intravenous injection of a novel growth hormone secretagogue in rats.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 9(6), 445-50

Citation

Malmlöf, K; Johansen, P B; Haahr, P M; Wilken, M; Oxlund, H. (1999). Methylprednisolone does not inhibit the release of growth hormone after intravenous injection of a novel growth hormone secretagogue in rats.. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 9(6), 445-50.